Gastrointestinal Dysautonomia After Immune Checkpoint Inhibitor Therapy: A Case Series and Systematic Review
ICI-induced GI dysautonomia is a potentially life-threatening IrAE requiring early recognition and effective immunosuppression to optimize outcome.
Authors
- Amna Sheri (ORCID: https://orcid.org/0000-0001-7517-8709)
- Natalia Zarate-Lopez
- Aisling Carr
- Emine Hatipoglu (ORCID: https://orcid.org/0000-0002-2278-4585)
- Emily Keen
- Diego Kaski (ORCID: https://orcid.org/0000-0002-0591-646X)
- Robin L. Jones (ORCID: https://orcid.org/0000-0003-4173-3844)
- Valeria Iodice (ORCID: https://orcid.org/0000-0001-7400-5611)
- Ross Nortley (ORCID: https://orcid.org/0000-0001-9967-4774)
- Stefan Sennfält (ORCID: https://orcid.org/0000-0002-7114-2757)
- Benjamin Norton (ORCID: https://orcid.org/0000-0003-2058-3162)
- Paul Nathan (ORCID: https://orcid.org/0000-0002-2327-3250)
- Anton Emmanuel (ORCID: https://orcid.org/0000-0002-0935-1128)
- Patricia A. Hill
- Annabelle Tala Jarjis
Institutions
- Institute of Cancer Research (GB)
- Queen Mary University of London (GB)
- The Royal Free Hospital (GB)
- Hammersmith Hospital (GB)
- Mount Vernon Cancer Centre (GB)
- Royal Marsden Hospital (GB)
- Institute of Ophthalmology (MX)
- Cleveland Clinic London (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2025-11-30
- DOI
- https://doi.org/10.1111/nmo.70212
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39